The Impact of Acupuncture on the Success Rates of IVF (In Vitro Fertilisation) Treatments
Launched by HOMERTON UNIVERSITY HOSPITAL NHS FOUNDATION TRUST · Feb 12, 2016
Trial Information
Current as of May 29, 2025
Completed
Keywords
ClinConnect Summary
Failing to conceive naturally poses significant stress to the infertile couple. It creates a feeling of failure and frustration. It has been found that the use of complementary therapies makes women feel empowered, with a sense of regaining control of the body.
The popularity of acupuncture is increasing. A significant proportion of couples having fertility treatment, especially IVF (In-Vitro Fertilisation) ask their clinician about using acupuncture and some patients undergo acupuncture privately without reporting to their clinicians.
The effectiveness of acupuncture on IVF has been exte...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Women under the age of 43 years with a BMI of less than 30 undergoing 1st or no more than their 2nd failed fresh IVF or ICSI cycle.
- Exclusion Criteria:
- • Those women undergoing frozen embryo replacement cycle or receiving donor eggs, BMI \> 30 or currently having acupuncture/ any other form of CAM, having contraindication to acupuncture like those with HIV, Hep C will be excluded.
About Homerton University Hospital Nhs Foundation Trust
Homerton University Hospital NHS Foundation Trust is a leading healthcare institution located in East London, dedicated to providing high-quality patient care and advancing medical research. As a prominent clinical trial sponsor, the Trust is committed to facilitating innovative studies that enhance treatment options and improve health outcomes. With a strong emphasis on collaboration and ethical practices, the Trust fosters an environment where cutting-edge research can thrive, leveraging its multidisciplinary expertise and state-of-the-art facilities to support the development of new therapies and interventions across various medical fields.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Karin Gillerman
Principal Investigator
NHS Honorary Contract
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials